Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.

Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ.

BMC Neurol. 2015 Apr 1;15:51. doi: 10.1186/s12883-015-0298-0.

2.

Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.

Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, Martins RN; AIBL Research Group.

Alzheimers Res Ther. 2015 Feb 20;7(1):16. doi: 10.1186/s13195-015-0105-6. eCollection 2015.

3.

The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review.

Sutton TA, Sohrabi HR, Rainey-Smith SR, Bird SM, Weinborn M, Martins RN.

Transl Psychiatry. 2015 Mar 31;5:e539. doi: 10.1038/tp.2015.39. Review.

PMID:
25826114
4.

Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity.

Moussavi Nik SH, Newman M, Wilson L, Ebrahimie E, Wells S, Musgrave I, Verdile G, Martins RN, Lardelli M.

Hum Mol Genet. 2015 Mar 26. pii: ddv110. [Epub ahead of print]

PMID:
25814654
5.

Bone mineral density, adiposity, and cognitive functions.

Sohrabi HR, Bates KA, Weinborn M, Bucks RS, Rainey-Smith SR, Rodrigues MA, Bird SM, Brown BM, Beilby J, Howard M, Criddle A, Wraith M, Taddei K, Martins G, Paton A, Shah T, Dhaliwal SS, Mehta PD, Foster JK, Martins IJ, Lautenschlager NT, Mastaglia F, Laws SM, Martins RN.

Front Aging Neurosci. 2015 Feb 18;7:16. doi: 10.3389/fnagi.2015.00016. eCollection 2015.

6.

Phenomenological Characterization of Memory Complaints in Preclinical and Prodromal Alzheimer's Disease.

Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM; The Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group.

Neuropsychology. 2015 Feb 9. [Epub ahead of print]

PMID:
25664464
7.

Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer's Disease: Baseline Data from a DIAN Cohort Subset.

Chatterjee P, Gupta VB, Fagan AM, Jasielec MS, Xiong C, Sohrabi HR, Dhaliwal S, Taddei K, Bourgeat P, Brown BM, Benzinger T, Bateman RJ, Morris JC, Martins RN.

Curr Alzheimer Res. 2015;12(2):157-64.

PMID:
25654503
8.

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.

Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P; Australian Imaging, Biomarkers, and Lifestyle Research Group.

JAMA Psychiatry. 2015 Mar;72(3):284-91. doi: 10.1001/jamapsychiatry.2014.2476.

PMID:
25629787
9.

Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease.

Rembach A, Stingo FC, Peterson C, Vannucci M, Do KA, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD; AIBL Research Group.

J Alzheimers Dis. 2015 Jan 1;44(3):917-25. doi: 10.3233/JAD-141497.

PMID:
25613103
10.

Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.

Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.

Neurobiol Aging. 2015 Mar;36(3):1231-8. doi: 10.1016/j.neurobiolaging.2014.12.015. Epub 2014 Dec 20.

PMID:
25585532
11.

APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.

Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.

Neurobiol Aging. 2015 Mar;36(3):1239-44. doi: 10.1016/j.neurobiolaging.2014.12.008. Epub 2014 Dec 11.

PMID:
25559335
12.

Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease.

Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P.

BMC Bioinformatics. 2014;15 Suppl 16:S11. doi: 10.1186/1471-2105-15-S16-S11. Epub 2014 Dec 8.

13.

Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.

Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P.

Arch Clin Neuropsychol. 2015 Feb;30(1):49-58. doi: 10.1093/arclin/acu068. Epub 2014 Dec 2.

PMID:
25467942
14.

A combination of physical activity and computerized brain training improves verbal memory and increases cerebral glucose metabolism in the elderly.

Shah T, Verdile G, Sohrabi H, Campbell A, Putland E, Cheetham C, Dhaliwal S, Weinborn M, Maruff P, Darby D, Martins RN.

Transl Psychiatry. 2014 Dec 2;4:e487. doi: 10.1038/tp.2014.122.

15.

Innovative diagnostic tools for early detection of Alzheimer's disease.

Laske C, Sohrabi HR, Frost SM, López-de-Ipiña K, Garrard P, Buscema M, Dauwels J, Soekadar SR, Mueller S, Linnemann C, Bridenbaugh SA, Kanagasingam Y, Martins RN, O'Bryant SE.

Alzheimers Dement. 2014 Nov 15. pii: S1552-5260(14)02463-7. doi: 10.1016/j.jalz.2014.06.004. [Epub ahead of print] Review.

PMID:
25443858
16.

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.

Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN.

Neurodegener Dis Manag. 2014;4(5):363-78. doi: 10.2217/nmt.14.29.

PMID:
25405650
17.

A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study.

Johnson LA, Sohrabi HR, Hall JR, Kevin T, Edwards M, O'Bryant SE, Martins RN.

Int J Geriatr Psychiatry. 2014 Nov 13. doi: 10.1002/gps.4231. [Epub ahead of print]

PMID:
25394326
18.

Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.

Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF.

Mol Psychiatry. 2014 Oct 28. doi: 10.1038/mp.2014.127. [Epub ahead of print]

PMID:
25349172
19.

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.

Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P.

Mol Psychiatry. 2014 Oct 7. doi: 10.1038/mp.2014.123. [Epub ahead of print]

PMID:
25288138
20.

[Construction and validation of a socio-environmental vulnerability index for monitoring and management of natural disasters in the state of Rio de Janeiro, Brazil].

Guimarães RM, Mazoto ML, Martins RN, do Carmo CN, Asmus CI.

Cien Saude Colet. 2014 Oct;19(10):4157-65. Portuguese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk